Apatinib for Inoperable Advanced Chondrosarcoma
NCT04260113
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Efficacy
Toxicity, Drug
Interventions
DRUG:
Apatinib Mesylate
Sponsor
Peking University People's Hospital